RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-08d14910473b75b6GRADE VERY_LOW
collagen peptides constituents — skin
direction BENEFIT · dose 10.0 g; 200 mg/kg; 300 mg/kg; 40 g; 5 g; 600 mg/kg · duration 10 weeks; 12 week; 12 weeks; 16 weeks; 24 weeks; 28 days; 4 weeks; 56 days; 8 weeks; 90 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
40bound studies
Bound studies (4 shown of 40)
STU-220934e343a01f10IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-2286b66ca916308cIN_VITRO · IN_VITRO · 2020 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-238e654348fc387eIN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-2624ade1c467875aANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
n 67 · validated
Opposition screen
SCREEN · 58 candidates considered · 0 bound as opposing
SYNTHESIS SYN-5e04e368117201 — outcome QUALITATIVE_ONLY · BENEFIT ×40 · not_assessed_quantitatively · 40 members
PROVENANCE → epmc:PPR1127473, epmc:32098294, epmc:PPR1172956 · PKG a738822294eb9c05…
CLAIM · CLM-78645e07f2e0914eGRADE VERY_LOW
collagen peptides constituents — weight
direction BENEFIT · dose 1 g/kg; 15 g; 300 mg/kg; 38 g; 600 mg/kg; 9.0 g/kg · duration 12 weeks; 28 days; 4 weeks; 6 weeks; 8 weeks; 90 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
21bound studies
Bound studies (4 shown of 21)
STU-00e62864f096f3ddMETA_ANALYSIS · ANIMAL · 2026 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-1b5fade594ca2c03RCT · HUMAN · 2019 · RoB SOME_CONCERNS
2 endpoints
STU-27b84950502f3ba4ANIMAL · ANIMAL · 2023 · 6 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-2b151df29dee8acaRCT · HUMAN · 2025 · RoB SOME_CONCERNS
2 endpoints
Quantitative observations
effect smd = -1.87) · directly reported
p_value p = 0.01 · validated
n 339 · validated
Opposition screen
SCREEN · 24 candidates considered · 0 bound as opposing
SYNTHESIS SYN-9731b386ee4c74 — outcome QUALITATIVE_ONLY · BENEFIT ×21 · not_assessed_quantitatively · 21 members
PROVENANCE → epmc:41168365, epmc:31091754, epmc:37200797 · PKG a738822294eb9c05…
Bounded preview — representative records only. The full release ships 24 claims and 267 observations.